|
|
|
||
1. Horáček,R., Čada, K., Hajn, P.: Práva k průmyslovému vlastnictví. 2. doplněné a přepracované vydání, C. H. Beck, Praha 2011 2. Svačina, P.: Oceňování nehmotného majetku 3. Čada, K.: Chránit či nechránit / to je otázka. Výsledky výzkumu a vývoje, jejich ochrana a komercializace. Alevia, 2014 4. Mařík, M.: Oceňování podniku - metody a postupy, Ekopress 2018 5. Scholleová, H.: Hodnota flexbility - Reálné opce, 2009 6. Zákon č. 121/2000 Sb., autorský zákon, v platném znění 7. Zákon č. 527/1990 Sb., o vynálezech a zlepšovacích návrzích, v platném znění Last update: Scholleová Hana (20.02.2021)
|
|
||
Zápočet - průběžná práce, průběžné testy min 50 %. Zkouška - ústní obhajoba projektu. Last update: Scholleová Hana (20.02.2021)
|
|
||
1. Technology transfer – general introduction and legal consequences. Technology transfer offices, its role and agenda. 2. Legal framework. 3. Academy to business (A2B) collaboration models. Legal and ethical questions. (Contracted research, sponsored research, collaborative research, Licensing, Spin-off, joint venture… 4. Project development, TLR, proof of concept, feasibility study and Business plan. 5. Market potential and generators of value of innovative technologies. Model of market niche, Novel markets development, migration of the technology. Strategic analysis. 7. Intellectual property rights. Patent protection, utility model, industrial design, trademarks, trade secrets, copy rights/authorship. Field specifies (engineering, Biotech, Software). 8. License agreements – its structure and crucial parts. Spin-off (or Joint venture) model of collaboration – its structure, shareholders. 9. Market size identification. Market data search. Prior-art benchmark, Innovativeness, Positioning, Market need, Market perception, 10. From sales to profit – top-down and bottom-up approach, license analogy. License fee and revenue-share based deal structure. 11. Risk and its evaluation WACC 12. Market valuation of RnD research – Why and how?: Value based management, investment opportunity analysis, Fair/objectivized value 13. Valuation methods and its use in valuation of RnD results: Cost-based methods, Valuation multiplicators approach, Income based valuation methods, NPV and DCF, License analogy, rNPV, real options 14. Investor perspective: financial/strategic investor, ROI, IRR, risk management tools: convertible bond financing, priority shares, veto rights Last update: Scholleová Hana (20.02.2021)
|